FundedIQ
Biotechnology

NeuroLife: Funding, Investors & Team (Sep 2026)

NeuroLife is a neurotechnology company bringing more than a decade of research and development into a focused effort to advance wearable neural interface systems.

www.neurolifetech.com LinkedIn Columbus, United States 1-10 employees
Biotechnology Neuroscience B2B
Total raised
$2.9M
Rounds
1
Latest
Seed
Jun 2026

NeuroLife has raised $2.9M across 1 funding round on record, the most recent a Seed of $2.9M announced in Jun 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

NeuroLife Company Profile and Key Stats

Total funding raised
$2.9M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$2.9M in Jun 2026
Employees
1-10
reported band
Headquarters
Columbus, United States

Latest funding round on record: Jun 2026.

NeuroLife Funding Rounds

Date
Round
Amount
Seed
$2.9M

NeuroLife Founders and Leadership Team

Name
Role
Contact
Jon Snyder
Founder

No contact details are on record for this team yet.

NeuroLife Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
16,485
$3.1M

NeuroLife's latest round of $2.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NeuroLife in Biotechnology and Columbus

Companies Similar to NeuroLife

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

NeuroLife Funding FAQs

What does NeuroLife do?

NeuroLife is a neurotechnology company bringing more than a decade of research and development into a focused effort to advance wearable neural interface systems.

How much funding has NeuroLife raised?

NeuroLife has raised $2.9M across 1 round on record. The most recent is a Seed of $2.9M announced in Jun 2026.

When did NeuroLife last raise funding?

NeuroLife's most recent funding round on record is a Seed of $2.9M, announced in Jun 2026.

Who founded NeuroLife?

FundedIQ lists Jon Snyder (Founder) at NeuroLife.

Where is NeuroLife headquartered?

NeuroLife is based in Columbus, Ohio, United States.

How many employees does NeuroLife have?

NeuroLife is in the 1-10 employee band.

How does NeuroLife's funding compare to other Biotechnology startups?

NeuroLife's latest round of $2.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's NeuroLife Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeuroLife is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.